Michael Buckstein, MD, PhD

Michael Buckstein, M.D., Ph.D. is a radiation oncologist specializing in the treatment of gastrointestinal tumors including the esophagus, stomach, pancreas, liver, gall bladder, bile ducts, rectum, and anus as well coronary brachytherapy.  He uses many advanced techniques such Intensity Modulated Radiation Therapy (IMRT), Image Guided Radiation Therapy (IGRT), Stereotactic Body Radiation Therapy (SBRT), and brachytherapy to maximize local control and cure of the cancer while minimizing radiation side effects to healthy tissue.

Dr. Buckstein graduated from Yale University and received both a medical and doctoral degree from the University of Pennsylvania School of Medicine.   His Ph.D. dissertation focused on the biochemical changes that affect the growth patterns of cells.  He completed his Medical Internship at Long Island Jewish Medical Center and his Residency in Radiation Oncology at the Icahn School of Medicine at Mount Sinai where he served as Chief Resident. 

Dr. Buckstein’s primary research focus is attempting to identify causes and limit treatment related toxicity from radiation therapy.  In addition to large retrospective reviews identifying factors involved in disease outcomes and toxicity, he is also heavily involved in projects using genomics to identify specific individuals at risk for developing adverse side effects from treatment. He was involved in a novel study identifying genetic factors predictive for the development of erectile dysfunction following radiation for prostate cancer.  His work has resulted in multiple presentations at international meetings as well publication in peer reviewed journals.